# Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2

> **NCT00002017** · NA · COMPLETED · sponsor: **Rockefeller University**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Interleukin-2, Polyethylene Glycolated

## Key facts

- **NCT ID:** NCT00002017
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002017, "Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00002017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*